Showing 1 - 20 results of 36 for search '(( significant clinical decrease ) OR ( significant ((mean decrease) OR (greater decrease)) ))~', query time: 0.53s Refine Results
  1. 1
  2. 2

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    “…Study limitations that affect the generalizability of results include a small sample size, homogenous study population, and significant differences in intervention intensity.</p><p>Conclusions</p><p>This trial met its primary endpoint: group psilocybin-assisted therapy plus MBSR was associated with clinically significant improvement in depressive symptoms without serious AEs and with greater reduction in symptoms than MBSR alone. …”
  3. 3

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    “…Study limitations that affect the generalizability of results include a small sample size, homogenous study population, and significant differences in intervention intensity.</p><p>Conclusions</p><p>This trial met its primary endpoint: group psilocybin-assisted therapy plus MBSR was associated with clinically significant improvement in depressive symptoms without serious AEs and with greater reduction in symptoms than MBSR alone. …”
  4. 4

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    “…Study limitations that affect the generalizability of results include a small sample size, homogenous study population, and significant differences in intervention intensity.</p><p>Conclusions</p><p>This trial met its primary endpoint: group psilocybin-assisted therapy plus MBSR was associated with clinically significant improvement in depressive symptoms without serious AEs and with greater reduction in symptoms than MBSR alone. …”
  5. 5

    Data Sheet 1_Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation—patients with AF produce lower SN levels than healthy individuals: the SAFE r... by Jiří Plášek (21805048)

    Published 2025
    “…Plasma SN levels were compared before, during, and after ablation and with those of healthy individuals, with nonparametric tests. ClinicalTrials.gov ID: NCT05794464.</p>Results<p>A total of 137 patients (64% males, age 63 ± 11) and 34 healthy individuals (38% males, mean age 31 ± 7.1) were included in the analysis. …”
  6. 6
  7. 7
  8. 8

    Table 1_Cutaneous sensory symptoms and emotional regulation in non-clinical healthy students: a near-infrared spectroscopy study.docx by Sachiyo Ozawa (22289089)

    Published 2025
    “…Background<p>In an era of increasing societal stress, greater attention must be given to the mental health and well-being of non-clinical populations. …”
  9. 9

    DataSheet1_Hypoglycemic activity of Garcinia mangostana L. extracts on diabetes rodent models: A systematic review and network meta-analysis.docx by Moragot Chatatikun (14682400)

    Published 2024
    “…All GM extracts showed greater effectiveness than the control in decreasing blood glucose levels within 2 weeks. …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Table 1_Clinical outcomes and psychosomatic correlates of integrative inpatient care based on Traditional Korean Medicine for acute neck and low back pain following traffic acciden... by Yohwan Kim (5482454)

    Published 2025
    “…On admission, the axial pain Numeric Rating Scale scores were positively correlated with the Insomnia Severity Index and Patient Health Questionnaire-9. Greater reductions in axial pain, as measured by Numeric Rating Scale scores, were significantly associated with decreases in scores on the Beck Anxiety Inventory, Fatigue Severity Scale, Patient Health Questionnaire-9, and Insomnia Severity Index in regression analyses adjusted for clinical and demographic covariates. …”
  16. 16

    Supplementary Material for: Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio... by figshare admin karger (2628495)

    Published 2025
    “…In VOYAGE I, NLR (p=0.011), PLR (p=0.015) and MLR (p=0.004) decreased significantly following 16 weeks of guselkumab treatment vs. placebo. …”
  17. 17
  18. 18
  19. 19

    Optimisation of read depth, DNA quantity, and unique alternate observation threshold. by Melinda L. Tursky (20790436)

    Published 2025
    “…Greater than 99.9% of variants detected were below ≥ 0.02 VAF, potentially including those with prognostic or predictive clinical relevance (F). …”
  20. 20

    pone.0331193.t003 - by Carol Kotliar (22351525)

    Published 2025
    “…</p><p>Design</p><p>Pilot clinical study, active-controlled, open randomization.…”